Manulife (Manufacturers Life Insurance)’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Buy
209,707
+32,221
+18% +$288K ﹤0.01% 1480
2025
Q4
$1.49M Buy
177,486
+15,021
+9% +$107K ﹤0.01% 1661
2025
Q3
$848K Sell
162,465
-49,661
-23% -$189K ﹤0.01% 1944
2025
Q2
$734K Buy
212,126
+6,547
+3% +$19.5K ﹤0.01% 1966
2025
Q1
$539K Sell
205,579
-13,293
-6% -$52.1K ﹤0.01% 2108
2024
Q4
$902K Buy
218,872
+3,325
+2% +$18.1K ﹤0.01% 1955
2024
Q3
$1.53M Sell
215,547
-41
-0% -$306 ﹤0.01% 1693
2024
Q2
$1.41M Sell
215,588
-19,598
-8% -$134K ﹤0.01% 1660
2024
Q1
$1.95M Sell
235,186
-3,870
-2% -$37.8K ﹤0.01% 1525
2023
Q4
$2.63M Sell
239,056
-1,040
-0.4% -$8.78K ﹤0.01% 1384
2023
Q3
$2.02M Buy
240,096
+34,535
+17% +$371K ﹤0.01% 1433
2023
Q2
$2.58M Buy
205,561
+37,406
+22% +$465K ﹤0.01% 1331
2023
Q1
$2.77M Buy
168,155
+61,822
+58% +$1.11M ﹤0.01% 1302
2022
Q4
$1.58M Buy
106,333
+3,188
+3% +$61K ﹤0.01% 1451
2022
Q3
$2.36M Buy
103,145
+6,977
+7% +$153K ﹤0.01% 1342
2022
Q2
$1.61M Buy
96,168
+7,606
+9% +$163K ﹤0.01% 1474
2022
Q1
$2.69M Buy
88,562
+53,376
+152% +$1.3M ﹤0.01% 1431
2021
Q4
$1.1K Buy
35,186
+3,992
+13% +$126K ﹤0.01% 1770
2021
Q3
$984K Sell
31,194
-1,955
-6% -$65.8K ﹤0.01% 1854
2021
Q2
$1.21M Buy
33,149
+7,020
+27% +$231K ﹤0.01% 1877
2021
Q1
$903K Buy
26,129
+6,345
+32% +$275K ﹤0.01% 1952
2020
Q4
$822K Buy
19,784
+2,187
+12% +$98.9K ﹤0.01% 1936
2020
Q3
$749K Buy
+17,597
New +$671K ﹤0.01% 1794

Other funds holding RLAY